Cancer Center Amsterdam
-
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study
COSTA study group, Mar 2026, In: The Lancet Gastroenterology and Hepatology. 11, 3, p. 190-203 14 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Appendicectomy plus standard medical therapy versus standard medical therapy alone for maintenance of remission in ulcerative colitis (ACCURE): a pragmatic, open-label, international, randomised trial
The ACCURE Study Group, 1 Jun 2025, In: The Lancet Gastroenterology and Hepatology. 10, 6, p. 550-561 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Bedside endoscopic inspection of colorectal anastomoses in the early postoperative period: a 2-center prospective feasibility study
Nijssen, D. J., Hompes, R., Tuynman, J., Wiggers, J. K., Bemelman, W. A., Sahid, S., Kinross, J. & Laméris, W., Apr 2025, In: Annals of Coloproctology. 41, 2, p. 127-135 9 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications